Archive for August, 2014

« Previous Entries

Blacks may have greater risk of diabetic vision loss

Sunday, August 31st, 2014

According to a new study, black people with diabetes may have a greater risk of suffering from vision loss due to diabetic macular edema or DME. However, DME is an effective screening tool that helps doctors treat the problem at early stages. The study was led by Rohit Varma, MD, MPH of the University of […]

WHO calls for e-cigarette indoor use, advertising regulations

Saturday, August 30th, 2014

Electronic cigarettes or e-cigarettes has sparked a continuing debate; with some experts arguing for it as a welcome smoking cessation tool and alternative and other experts calling it a regress to reduce smoking. The World Health Organization (WHO) has now given its own recommendations on the controversial e-cigarette, releasing a report on it and similar […]

Mental health screenings may improve cancer patient care

Thursday, August 28th, 2014

A recent study in the UK has found that many cancer patients suffer from depression but are not treated for it, and regular mental screenings can improve patient care. The study was led by Jane Walker, PhD, of the University of Oxford. Data on 21,000 cancer patients was analyzed for this study; they undertook a […]

Trans fat nutrition labels may not be accurate

Wednesday, August 27th, 2014

Trans fat serving levels on nutrition labels may not be accurate, according to a recent study that analyzed several popular packaged food items in the US. The study found that some products labeled with 0 gm trans fat per serving did have trans fat as partially hydrogenated oils. Hydrogenated oils are one of the most […]

NIH approves Ebola vaccine by NIAID and GlaxoSmithKline

Monday, August 25th, 2014

The US National Institutes of Health (NIH) has approved early testing of a new Ebola vaccine co-developed by GlaxoSmithKline and the National Institute of Allergy and Infectious Diseases (NIAID). As the death toll of the Ebola virus outbreak in West Africa continues to rise, NIH has scrambled to test the vaccine that could potentially slow […]

DEA classifies hydrocodone combination drugs as Schedule II

Sunday, August 24th, 2014

The US Drug Enforcement Administration (DEA) has reclassified hydrocodone combination drugs like Vicodin as Schedule II medication to combat widespread narcotic painkiller abuse in the country. Hydrocodone combination drugs, which were previously Schedule III, are some of the most commonly available painkillers in the US today. By shifting these drugs from Schedule III to Schedule […]

NSAIDs reduce recurrence of breast cancer in overweight, obese

Saturday, August 23rd, 2014

A recent study found that over-the-counter NSAIDs were able to lower the recurrence risk of hormone-related breast cancer in obese and overweight women. This study was led by Linda deGraffenried, PhD, at the University of Texas in Austin. A total of 440 women suffering from estrogen-positive invasive breast cancer were part of this study and […]

FDA warns of fraudulent Ebola treatments

Thursday, August 21st, 2014

In a recently issued statement, the US Food and Drug Administration (FDA) has warned against fake Ebola treatments and has threatened action against parties selling and promoting such treatments. The FDA also reiterated in its statement that it has not yet approved any medication to cure or prevent Ebola. Ebola virus disease is a severe […]

Chikungunya cases spike in Caribbean, not likely to cause US outbreak

Wednesday, August 20th, 2014

The number of cases of the viral infection chikungunya has risen significantly in the Western Hemisphere in the past few months, especially in the Caribbean area. Locally transmitted cases have been identified in Florida, but CDC officially believe that the virus is not likely to cause a major US outbreak. The CDC has reported 221 […]

Rates of bacterial meningitis fall in 1997-2010

Tuesday, August 19th, 2014

According to a new study, the rates of bacterial and pneumococcal meningitis mortality have dropped in 1997-2010, a period during which efforts to treat the condition went through significant changes. The study was led by Rodrigo Hasbun, MD, of the Department of Internal Medicine at the University of Texas Health Science Center in Houston and […]

« Previous Entries